Lacosamide.

Article Details

Citation
Copy to clipboard

Perucca E, Yasothan U, Clincke G, Kirkpatrick P

Lacosamide.

Nat Rev Drug Discov. 2008 Dec;7(12):973-4. doi: 10.1038/nrd2764.

PubMed ID
19043448 [ View in PubMed
]
Abstract

In August 2008, lacosamide (Vimpat; UCB), was granted market authorization by the European Commission as an adjunctive therapy for partial-onset seizures with or without secondary generalization in patients with epilepsy. It was approved by the FDA as an adjunctive therapy for partial-onset seizures in October 2008.

DrugBank Data that Cites this Article

Drugs